Applied DNA Sciences Announces Affiliation with Two Experts
08 December 2006 - 11:30PM
PR Newswire (US)
STONY BROOK, N.Y., Dec. 8 /PRNewswire-FirstCall/ -- Applied DNA
Sciences, Inc. (OTC:APDN) (BULLETIN BOARD: APDN) , a DNA security
solutions company, today announced that it has entered into
consulting agreements with two experts renowned in their fields of
work. John Twilley and Thomas A. Nicolette both bring to APDN years
of relevant experience which will be used by APDN as it grows its
customer base and pursues new and existing markets for its
SigNature(TM) Program. John Twilley is renowned in the field of art
conservation with over thirty years of experience. Mr. Twilley has
written numerous publications and over 600 unpublished scientific
reports on the conservation of art and related topics. Mr. Twilley
has held research positions in industry as well as serving as
Conservation Scientist at the J. Paul Getty Museum. He held the
position of Senior Research Scientist at the Conservation Center of
the Los Angeles County Museum of Art and taught art and artifacts
conservation at the graduate level within the University of
California for twenty years. Mr. Twilley is renowned for his
expertise in authentication and conservation of artworks, with a
recent emphasis on Asian Art. Mr. Twilley currently has a
successful independent practice in conservation science and is
assisting APDN in the area of art and collectibles as it pursues
this important target market. Fine art and collectibles are
especially vulnerable to counterfeiting, forgeries and fraud. APDN
believes that its SigNature(TM) DNA Markers can be safely embedded
directly in all forms of artwork and collectibles and thus can be
used to designate and authenticate these valuables. These DNA
Markers can also be embedded in any original supporting
documentation related to the artwork or collectibles, in the
signature of the artist and in any other relevant material that
would provide provenance. Mr. Twilley's expertise in art
conservation will assist APDN in the fine art and collectibles
market where material compatibility and longevity issues are
paramount and where unique security concerns exist, thereby helping
to penetrate this important market segment. Thomas A. Nicolette
brings over thirty years of experience with security solutions
companies to his association with APDN. Having previously held
senior management and Board of Director positions in the
Authentication and Anti-Shoplifting Industries, Mr. Nicolette
brings his knowledge of the industry and the competitive landscape
to APDN. Using this knowledge and experience, Mr. Nicolette will be
assisting APDN in developing new customers for APDN's SigNature(TM)
Program in its identified target markets worldwide. These markets
initially include fine wine, art and collectibles, consumer
products, digital and recording media, pharmaceuticals and homeland
security. Dr. James A. Hayward, CEO of APDN, stated, "We are
pleased to be working with these renowned gentlemen and we look
forward to the advice and expertise they bring to APDN. Their
knowledge and understanding of key issues will be helpful as we
further penetrate the target markets that APDN has already
identified and they will be instrumental in identifying new target
markets." About Applied DNA Sciences, Inc. Applied DNA Sciences,
Inc. (APDN) provides botanical DNA encryption, embedment and
authentication solutions that can help protect companies,
governments and consumers from counterfeiting, fraud, piracy,
product diversion, identity theft and unauthorized intrusion into
physical locations and databases. Our common stock is registered
under Section 12(g) of the Securities Exchange Act of 1934 and is
listed on the Over-The-Counter Bulletin Board under the symbol
"APDN." Contact: Debbie Bailey, Applied DNA Sciences, Inc., 25
Health Sciences Drive, Stony Brook, New York 11790; Tel: 631-444-
8090; Fax: 631-444-8848 http://www.adnas.com/. The statements made
by Applied DNA Sciences, Inc. may be forward-looking in nature and
are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements describe the Company's future plans, projections,
strategies and expectations, and are based on assumptions and
involve a number of risks and uncertainties, many of which are
beyond the control of Applied DNA Sciences, Inc. Actual results
could differ materially from those projected due to our short
operating history, limited market acceptance, market competition
and various other factors detailed from time to time in Applied DNA
Sciences' SEC reports and filings, including our Registration
Statement on Form SB-2 as amended, our Annual Report on Form
10-KSB, filed on January 12, 2006, our subsequent Quarterly Reports
on Form 10-QSB, and our Current Reports on Form 8-K. The Company
undertakes no obligation to update publicly any forward-looking
statements to reflect new information, events or circumstances
after the date hereof to reflect the occurrence of unanticipated
events. DATASOURCE: Applied DNA Sciences, Inc. CONTACT: Debbie
Bailey, +1-631-444-8090, fax: +1-631-444-8848 Web site:
http://www.adnas.com/
Copyright